Global Plasma-derived Therapies Market Research Report 2024(Status and Outlook)
Report Overview
Plasma-derived therapeutics start from human blood plasma instead of the chemical or synthetic materials from which most pharmaceuticals are made.
This report provides a deep insight into the global Plasma-derived Therapies market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Plasma-derived Therapies Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Plasma-derived Therapies market in any manner.
Global Plasma-derived Therapies Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
CSL Behring LLC
Shire
Bayer
Kedrion
Takeda
Biotest
Octaparma
Bio Products Laboratory (BPL)
LFB
Grifols
Market Segmentation (by Type)
Albumin
Immunoglobulin
Factor VIII
Others
Market Segmentation (by Application)
Hemophilia
Primary Immunodeficiencies (PIDs)
Idiopathic Thrombocytopenic Purpura (ITP)
COVID-19
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Plasma-derived Therapies Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Plasma-derived therapeutics start from human blood plasma instead of the chemical or synthetic materials from which most pharmaceuticals are made.
This report provides a deep insight into the global Plasma-derived Therapies market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Plasma-derived Therapies Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Plasma-derived Therapies market in any manner.
Global Plasma-derived Therapies Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
CSL Behring LLC
Shire
Bayer
Kedrion
Takeda
Biotest
Octaparma
Bio Products Laboratory (BPL)
LFB
Grifols
Market Segmentation (by Type)
Albumin
Immunoglobulin
Factor VIII
Others
Market Segmentation (by Application)
Hemophilia
Primary Immunodeficiencies (PIDs)
Idiopathic Thrombocytopenic Purpura (ITP)
COVID-19
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Plasma-derived Therapies Market
- Overview of the regional outlook of the Plasma-derived Therapies Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Plasma-derived Therapies Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Plasma-derived Therapies
1.2 Key Market Segments
1.2.1 Plasma-derived Therapies Segment by Type
1.2.2 Plasma-derived Therapies Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PLASMA-DERIVED THERAPIES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Plasma-derived Therapies Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Plasma-derived Therapies Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PLASMA-DERIVED THERAPIES MARKET COMPETITIVE LANDSCAPE
3.1 Global Plasma-derived Therapies Sales by Manufacturers (2019-2024)
3.2 Global Plasma-derived Therapies Revenue Market Share by Manufacturers (2019-2024)
3.3 Plasma-derived Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Plasma-derived Therapies Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Plasma-derived Therapies Sales Sites, Area Served, Product Type
3.6 Plasma-derived Therapies Market Competitive Situation and Trends
3.6.1 Plasma-derived Therapies Market Concentration Rate
3.6.2 Global 5 and 10 Largest Plasma-derived Therapies Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PLASMA-DERIVED THERAPIES INDUSTRY CHAIN ANALYSIS
4.1 Plasma-derived Therapies Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PLASMA-DERIVED THERAPIES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PLASMA-DERIVED THERAPIES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Plasma-derived Therapies Sales Market Share by Type (2019-2024)
6.3 Global Plasma-derived Therapies Market Size Market Share by Type (2019-2024)
6.4 Global Plasma-derived Therapies Price by Type (2019-2024)
7 PLASMA-DERIVED THERAPIES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Plasma-derived Therapies Market Sales by Application (2019-2024)
7.3 Global Plasma-derived Therapies Market Size (M USD) by Application (2019-2024)
7.4 Global Plasma-derived Therapies Sales Growth Rate by Application (2019-2024)
8 PLASMA-DERIVED THERAPIES MARKET SEGMENTATION BY REGION
8.1 Global Plasma-derived Therapies Sales by Region
8.1.1 Global Plasma-derived Therapies Sales by Region
8.1.2 Global Plasma-derived Therapies Sales Market Share by Region
8.2 North America
8.2.1 North America Plasma-derived Therapies Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Plasma-derived Therapies Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Plasma-derived Therapies Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Plasma-derived Therapies Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Plasma-derived Therapies Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 CSL Behring LLC
9.1.1 CSL Behring LLC Plasma-derived Therapies Basic Information
9.1.2 CSL Behring LLC Plasma-derived Therapies Product Overview
9.1.3 CSL Behring LLC Plasma-derived Therapies Product Market Performance
9.1.4 CSL Behring LLC Business Overview
9.1.5 CSL Behring LLC Plasma-derived Therapies SWOT Analysis
9.1.6 CSL Behring LLC Recent Developments
9.2 Shire
9.2.1 Shire Plasma-derived Therapies Basic Information
9.2.2 Shire Plasma-derived Therapies Product Overview
9.2.3 Shire Plasma-derived Therapies Product Market Performance
9.2.4 Shire Business Overview
9.2.5 Shire Plasma-derived Therapies SWOT Analysis
9.2.6 Shire Recent Developments
9.3 Bayer
9.3.1 Bayer Plasma-derived Therapies Basic Information
9.3.2 Bayer Plasma-derived Therapies Product Overview
9.3.3 Bayer Plasma-derived Therapies Product Market Performance
9.3.4 Bayer Plasma-derived Therapies SWOT Analysis
9.3.5 Bayer Business Overview
9.3.6 Bayer Recent Developments
9.4 Kedrion
9.4.1 Kedrion Plasma-derived Therapies Basic Information
9.4.2 Kedrion Plasma-derived Therapies Product Overview
9.4.3 Kedrion Plasma-derived Therapies Product Market Performance
9.4.4 Kedrion Business Overview
9.4.5 Kedrion Recent Developments
9.5 Takeda
9.5.1 Takeda Plasma-derived Therapies Basic Information
9.5.2 Takeda Plasma-derived Therapies Product Overview
9.5.3 Takeda Plasma-derived Therapies Product Market Performance
9.5.4 Takeda Business Overview
9.5.5 Takeda Recent Developments
9.6 Biotest
9.6.1 Biotest Plasma-derived Therapies Basic Information
9.6.2 Biotest Plasma-derived Therapies Product Overview
9.6.3 Biotest Plasma-derived Therapies Product Market Performance
9.6.4 Biotest Business Overview
9.6.5 Biotest Recent Developments
9.7 Octaparma
9.7.1 Octaparma Plasma-derived Therapies Basic Information
9.7.2 Octaparma Plasma-derived Therapies Product Overview
9.7.3 Octaparma Plasma-derived Therapies Product Market Performance
9.7.4 Octaparma Business Overview
9.7.5 Octaparma Recent Developments
9.8 Bio Products Laboratory (BPL)
9.8.1 Bio Products Laboratory (BPL) Plasma-derived Therapies Basic Information
9.8.2 Bio Products Laboratory (BPL) Plasma-derived Therapies Product Overview
9.8.3 Bio Products Laboratory (BPL) Plasma-derived Therapies Product Market Performance
9.8.4 Bio Products Laboratory (BPL) Business Overview
9.8.5 Bio Products Laboratory (BPL) Recent Developments
9.9 LFB
9.9.1 LFB Plasma-derived Therapies Basic Information
9.9.2 LFB Plasma-derived Therapies Product Overview
9.9.3 LFB Plasma-derived Therapies Product Market Performance
9.9.4 LFB Business Overview
9.9.5 LFB Recent Developments
9.10 Grifols
9.10.1 Grifols Plasma-derived Therapies Basic Information
9.10.2 Grifols Plasma-derived Therapies Product Overview
9.10.3 Grifols Plasma-derived Therapies Product Market Performance
9.10.4 Grifols Business Overview
9.10.5 Grifols Recent Developments
10 PLASMA-DERIVED THERAPIES MARKET FORECAST BY REGION
10.1 Global Plasma-derived Therapies Market Size Forecast
10.2 Global Plasma-derived Therapies Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Plasma-derived Therapies Market Size Forecast by Country
10.2.3 Asia Pacific Plasma-derived Therapies Market Size Forecast by Region
10.2.4 South America Plasma-derived Therapies Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Plasma-derived Therapies by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Plasma-derived Therapies Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Plasma-derived Therapies by Type (2025-2030)
11.1.2 Global Plasma-derived Therapies Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Plasma-derived Therapies by Type (2025-2030)
11.2 Global Plasma-derived Therapies Market Forecast by Application (2025-2030)
11.2.1 Global Plasma-derived Therapies Sales (K Units) Forecast by Application
11.2.2 Global Plasma-derived Therapies Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Plasma-derived Therapies
1.2 Key Market Segments
1.2.1 Plasma-derived Therapies Segment by Type
1.2.2 Plasma-derived Therapies Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PLASMA-DERIVED THERAPIES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Plasma-derived Therapies Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Plasma-derived Therapies Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PLASMA-DERIVED THERAPIES MARKET COMPETITIVE LANDSCAPE
3.1 Global Plasma-derived Therapies Sales by Manufacturers (2019-2024)
3.2 Global Plasma-derived Therapies Revenue Market Share by Manufacturers (2019-2024)
3.3 Plasma-derived Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Plasma-derived Therapies Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Plasma-derived Therapies Sales Sites, Area Served, Product Type
3.6 Plasma-derived Therapies Market Competitive Situation and Trends
3.6.1 Plasma-derived Therapies Market Concentration Rate
3.6.2 Global 5 and 10 Largest Plasma-derived Therapies Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PLASMA-DERIVED THERAPIES INDUSTRY CHAIN ANALYSIS
4.1 Plasma-derived Therapies Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PLASMA-DERIVED THERAPIES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PLASMA-DERIVED THERAPIES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Plasma-derived Therapies Sales Market Share by Type (2019-2024)
6.3 Global Plasma-derived Therapies Market Size Market Share by Type (2019-2024)
6.4 Global Plasma-derived Therapies Price by Type (2019-2024)
7 PLASMA-DERIVED THERAPIES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Plasma-derived Therapies Market Sales by Application (2019-2024)
7.3 Global Plasma-derived Therapies Market Size (M USD) by Application (2019-2024)
7.4 Global Plasma-derived Therapies Sales Growth Rate by Application (2019-2024)
8 PLASMA-DERIVED THERAPIES MARKET SEGMENTATION BY REGION
8.1 Global Plasma-derived Therapies Sales by Region
8.1.1 Global Plasma-derived Therapies Sales by Region
8.1.2 Global Plasma-derived Therapies Sales Market Share by Region
8.2 North America
8.2.1 North America Plasma-derived Therapies Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Plasma-derived Therapies Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Plasma-derived Therapies Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Plasma-derived Therapies Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Plasma-derived Therapies Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 CSL Behring LLC
9.1.1 CSL Behring LLC Plasma-derived Therapies Basic Information
9.1.2 CSL Behring LLC Plasma-derived Therapies Product Overview
9.1.3 CSL Behring LLC Plasma-derived Therapies Product Market Performance
9.1.4 CSL Behring LLC Business Overview
9.1.5 CSL Behring LLC Plasma-derived Therapies SWOT Analysis
9.1.6 CSL Behring LLC Recent Developments
9.2 Shire
9.2.1 Shire Plasma-derived Therapies Basic Information
9.2.2 Shire Plasma-derived Therapies Product Overview
9.2.3 Shire Plasma-derived Therapies Product Market Performance
9.2.4 Shire Business Overview
9.2.5 Shire Plasma-derived Therapies SWOT Analysis
9.2.6 Shire Recent Developments
9.3 Bayer
9.3.1 Bayer Plasma-derived Therapies Basic Information
9.3.2 Bayer Plasma-derived Therapies Product Overview
9.3.3 Bayer Plasma-derived Therapies Product Market Performance
9.3.4 Bayer Plasma-derived Therapies SWOT Analysis
9.3.5 Bayer Business Overview
9.3.6 Bayer Recent Developments
9.4 Kedrion
9.4.1 Kedrion Plasma-derived Therapies Basic Information
9.4.2 Kedrion Plasma-derived Therapies Product Overview
9.4.3 Kedrion Plasma-derived Therapies Product Market Performance
9.4.4 Kedrion Business Overview
9.4.5 Kedrion Recent Developments
9.5 Takeda
9.5.1 Takeda Plasma-derived Therapies Basic Information
9.5.2 Takeda Plasma-derived Therapies Product Overview
9.5.3 Takeda Plasma-derived Therapies Product Market Performance
9.5.4 Takeda Business Overview
9.5.5 Takeda Recent Developments
9.6 Biotest
9.6.1 Biotest Plasma-derived Therapies Basic Information
9.6.2 Biotest Plasma-derived Therapies Product Overview
9.6.3 Biotest Plasma-derived Therapies Product Market Performance
9.6.4 Biotest Business Overview
9.6.5 Biotest Recent Developments
9.7 Octaparma
9.7.1 Octaparma Plasma-derived Therapies Basic Information
9.7.2 Octaparma Plasma-derived Therapies Product Overview
9.7.3 Octaparma Plasma-derived Therapies Product Market Performance
9.7.4 Octaparma Business Overview
9.7.5 Octaparma Recent Developments
9.8 Bio Products Laboratory (BPL)
9.8.1 Bio Products Laboratory (BPL) Plasma-derived Therapies Basic Information
9.8.2 Bio Products Laboratory (BPL) Plasma-derived Therapies Product Overview
9.8.3 Bio Products Laboratory (BPL) Plasma-derived Therapies Product Market Performance
9.8.4 Bio Products Laboratory (BPL) Business Overview
9.8.5 Bio Products Laboratory (BPL) Recent Developments
9.9 LFB
9.9.1 LFB Plasma-derived Therapies Basic Information
9.9.2 LFB Plasma-derived Therapies Product Overview
9.9.3 LFB Plasma-derived Therapies Product Market Performance
9.9.4 LFB Business Overview
9.9.5 LFB Recent Developments
9.10 Grifols
9.10.1 Grifols Plasma-derived Therapies Basic Information
9.10.2 Grifols Plasma-derived Therapies Product Overview
9.10.3 Grifols Plasma-derived Therapies Product Market Performance
9.10.4 Grifols Business Overview
9.10.5 Grifols Recent Developments
10 PLASMA-DERIVED THERAPIES MARKET FORECAST BY REGION
10.1 Global Plasma-derived Therapies Market Size Forecast
10.2 Global Plasma-derived Therapies Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Plasma-derived Therapies Market Size Forecast by Country
10.2.3 Asia Pacific Plasma-derived Therapies Market Size Forecast by Region
10.2.4 South America Plasma-derived Therapies Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Plasma-derived Therapies by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Plasma-derived Therapies Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Plasma-derived Therapies by Type (2025-2030)
11.1.2 Global Plasma-derived Therapies Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Plasma-derived Therapies by Type (2025-2030)
11.2 Global Plasma-derived Therapies Market Forecast by Application (2025-2030)
11.2.1 Global Plasma-derived Therapies Sales (K Units) Forecast by Application
11.2.2 Global Plasma-derived Therapies Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Plasma-derived Therapies Market Size Comparison by Region (M USD)
Table 5. Global Plasma-derived Therapies Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Plasma-derived Therapies Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Plasma-derived Therapies Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Plasma-derived Therapies Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma-derived Therapies as of 2022)
Table 10. Global Market Plasma-derived Therapies Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Plasma-derived Therapies Sales Sites and Area Served
Table 12. Manufacturers Plasma-derived Therapies Product Type
Table 13. Global Plasma-derived Therapies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Plasma-derived Therapies
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Plasma-derived Therapies Market Challenges
Table 22. Global Plasma-derived Therapies Sales by Type (K Units)
Table 23. Global Plasma-derived Therapies Market Size by Type (M USD)
Table 24. Global Plasma-derived Therapies Sales (K Units) by Type (2019-2024)
Table 25. Global Plasma-derived Therapies Sales Market Share by Type (2019-2024)
Table 26. Global Plasma-derived Therapies Market Size (M USD) by Type (2019-2024)
Table 27. Global Plasma-derived Therapies Market Size Share by Type (2019-2024)
Table 28. Global Plasma-derived Therapies Price (USD/Unit) by Type (2019-2024)
Table 29. Global Plasma-derived Therapies Sales (K Units) by Application
Table 30. Global Plasma-derived Therapies Market Size by Application
Table 31. Global Plasma-derived Therapies Sales by Application (2019-2024) & (K Units)
Table 32. Global Plasma-derived Therapies Sales Market Share by Application (2019-2024)
Table 33. Global Plasma-derived Therapies Sales by Application (2019-2024) & (M USD)
Table 34. Global Plasma-derived Therapies Market Share by Application (2019-2024)
Table 35. Global Plasma-derived Therapies Sales Growth Rate by Application (2019-2024)
Table 36. Global Plasma-derived Therapies Sales by Region (2019-2024) & (K Units)
Table 37. Global Plasma-derived Therapies Sales Market Share by Region (2019-2024)
Table 38. North America Plasma-derived Therapies Sales by Country (2019-2024) & (K Units)
Table 39. Europe Plasma-derived Therapies Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Plasma-derived Therapies Sales by Region (2019-2024) & (K Units)
Table 41. South America Plasma-derived Therapies Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Plasma-derived Therapies Sales by Region (2019-2024) & (K Units)
Table 43. CSL Behring LLC Plasma-derived Therapies Basic Information
Table 44. CSL Behring LLC Plasma-derived Therapies Product Overview
Table 45. CSL Behring LLC Plasma-derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. CSL Behring LLC Business Overview
Table 47. CSL Behring LLC Plasma-derived Therapies SWOT Analysis
Table 48. CSL Behring LLC Recent Developments
Table 49. Shire Plasma-derived Therapies Basic Information
Table 50. Shire Plasma-derived Therapies Product Overview
Table 51. Shire Plasma-derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Shire Business Overview
Table 53. Shire Plasma-derived Therapies SWOT Analysis
Table 54. Shire Recent Developments
Table 55. Bayer Plasma-derived Therapies Basic Information
Table 56. Bayer Plasma-derived Therapies Product Overview
Table 57. Bayer Plasma-derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Bayer Plasma-derived Therapies SWOT Analysis
Table 59. Bayer Business Overview
Table 60. Bayer Recent Developments
Table 61. Kedrion Plasma-derived Therapies Basic Information
Table 62. Kedrion Plasma-derived Therapies Product Overview
Table 63. Kedrion Plasma-derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Kedrion Business Overview
Table 65. Kedrion Recent Developments
Table 66. Takeda Plasma-derived Therapies Basic Information
Table 67. Takeda Plasma-derived Therapies Product Overview
Table 68. Takeda Plasma-derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Takeda Business Overview
Table 70. Takeda Recent Developments
Table 71. Biotest Plasma-derived Therapies Basic Information
Table 72. Biotest Plasma-derived Therapies Product Overview
Table 73. Biotest Plasma-derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Biotest Business Overview
Table 75. Biotest Recent Developments
Table 76. Octaparma Plasma-derived Therapies Basic Information
Table 77. Octaparma Plasma-derived Therapies Product Overview
Table 78. Octaparma Plasma-derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Octaparma Business Overview
Table 80. Octaparma Recent Developments
Table 81. Bio Products Laboratory (BPL) Plasma-derived Therapies Basic Information
Table 82. Bio Products Laboratory (BPL) Plasma-derived Therapies Product Overview
Table 83. Bio Products Laboratory (BPL) Plasma-derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Bio Products Laboratory (BPL) Business Overview
Table 85. Bio Products Laboratory (BPL) Recent Developments
Table 86. LFB Plasma-derived Therapies Basic Information
Table 87. LFB Plasma-derived Therapies Product Overview
Table 88. LFB Plasma-derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. LFB Business Overview
Table 90. LFB Recent Developments
Table 91. Grifols Plasma-derived Therapies Basic Information
Table 92. Grifols Plasma-derived Therapies Product Overview
Table 93. Grifols Plasma-derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Grifols Business Overview
Table 95. Grifols Recent Developments
Table 96. Global Plasma-derived Therapies Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Plasma-derived Therapies Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Plasma-derived Therapies Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Plasma-derived Therapies Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Plasma-derived Therapies Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Plasma-derived Therapies Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Plasma-derived Therapies Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Plasma-derived Therapies Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Plasma-derived Therapies Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Plasma-derived Therapies Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Plasma-derived Therapies Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Plasma-derived Therapies Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Plasma-derived Therapies Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Plasma-derived Therapies Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Plasma-derived Therapies Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Plasma-derived Therapies Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Plasma-derived Therapies Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Plasma-derived Therapies Market Size Comparison by Region (M USD)
Table 5. Global Plasma-derived Therapies Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Plasma-derived Therapies Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Plasma-derived Therapies Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Plasma-derived Therapies Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma-derived Therapies as of 2022)
Table 10. Global Market Plasma-derived Therapies Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Plasma-derived Therapies Sales Sites and Area Served
Table 12. Manufacturers Plasma-derived Therapies Product Type
Table 13. Global Plasma-derived Therapies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Plasma-derived Therapies
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Plasma-derived Therapies Market Challenges
Table 22. Global Plasma-derived Therapies Sales by Type (K Units)
Table 23. Global Plasma-derived Therapies Market Size by Type (M USD)
Table 24. Global Plasma-derived Therapies Sales (K Units) by Type (2019-2024)
Table 25. Global Plasma-derived Therapies Sales Market Share by Type (2019-2024)
Table 26. Global Plasma-derived Therapies Market Size (M USD) by Type (2019-2024)
Table 27. Global Plasma-derived Therapies Market Size Share by Type (2019-2024)
Table 28. Global Plasma-derived Therapies Price (USD/Unit) by Type (2019-2024)
Table 29. Global Plasma-derived Therapies Sales (K Units) by Application
Table 30. Global Plasma-derived Therapies Market Size by Application
Table 31. Global Plasma-derived Therapies Sales by Application (2019-2024) & (K Units)
Table 32. Global Plasma-derived Therapies Sales Market Share by Application (2019-2024)
Table 33. Global Plasma-derived Therapies Sales by Application (2019-2024) & (M USD)
Table 34. Global Plasma-derived Therapies Market Share by Application (2019-2024)
Table 35. Global Plasma-derived Therapies Sales Growth Rate by Application (2019-2024)
Table 36. Global Plasma-derived Therapies Sales by Region (2019-2024) & (K Units)
Table 37. Global Plasma-derived Therapies Sales Market Share by Region (2019-2024)
Table 38. North America Plasma-derived Therapies Sales by Country (2019-2024) & (K Units)
Table 39. Europe Plasma-derived Therapies Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Plasma-derived Therapies Sales by Region (2019-2024) & (K Units)
Table 41. South America Plasma-derived Therapies Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Plasma-derived Therapies Sales by Region (2019-2024) & (K Units)
Table 43. CSL Behring LLC Plasma-derived Therapies Basic Information
Table 44. CSL Behring LLC Plasma-derived Therapies Product Overview
Table 45. CSL Behring LLC Plasma-derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. CSL Behring LLC Business Overview
Table 47. CSL Behring LLC Plasma-derived Therapies SWOT Analysis
Table 48. CSL Behring LLC Recent Developments
Table 49. Shire Plasma-derived Therapies Basic Information
Table 50. Shire Plasma-derived Therapies Product Overview
Table 51. Shire Plasma-derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Shire Business Overview
Table 53. Shire Plasma-derived Therapies SWOT Analysis
Table 54. Shire Recent Developments
Table 55. Bayer Plasma-derived Therapies Basic Information
Table 56. Bayer Plasma-derived Therapies Product Overview
Table 57. Bayer Plasma-derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Bayer Plasma-derived Therapies SWOT Analysis
Table 59. Bayer Business Overview
Table 60. Bayer Recent Developments
Table 61. Kedrion Plasma-derived Therapies Basic Information
Table 62. Kedrion Plasma-derived Therapies Product Overview
Table 63. Kedrion Plasma-derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Kedrion Business Overview
Table 65. Kedrion Recent Developments
Table 66. Takeda Plasma-derived Therapies Basic Information
Table 67. Takeda Plasma-derived Therapies Product Overview
Table 68. Takeda Plasma-derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Takeda Business Overview
Table 70. Takeda Recent Developments
Table 71. Biotest Plasma-derived Therapies Basic Information
Table 72. Biotest Plasma-derived Therapies Product Overview
Table 73. Biotest Plasma-derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Biotest Business Overview
Table 75. Biotest Recent Developments
Table 76. Octaparma Plasma-derived Therapies Basic Information
Table 77. Octaparma Plasma-derived Therapies Product Overview
Table 78. Octaparma Plasma-derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Octaparma Business Overview
Table 80. Octaparma Recent Developments
Table 81. Bio Products Laboratory (BPL) Plasma-derived Therapies Basic Information
Table 82. Bio Products Laboratory (BPL) Plasma-derived Therapies Product Overview
Table 83. Bio Products Laboratory (BPL) Plasma-derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Bio Products Laboratory (BPL) Business Overview
Table 85. Bio Products Laboratory (BPL) Recent Developments
Table 86. LFB Plasma-derived Therapies Basic Information
Table 87. LFB Plasma-derived Therapies Product Overview
Table 88. LFB Plasma-derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. LFB Business Overview
Table 90. LFB Recent Developments
Table 91. Grifols Plasma-derived Therapies Basic Information
Table 92. Grifols Plasma-derived Therapies Product Overview
Table 93. Grifols Plasma-derived Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Grifols Business Overview
Table 95. Grifols Recent Developments
Table 96. Global Plasma-derived Therapies Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Plasma-derived Therapies Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Plasma-derived Therapies Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Plasma-derived Therapies Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Plasma-derived Therapies Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Plasma-derived Therapies Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Plasma-derived Therapies Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Plasma-derived Therapies Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Plasma-derived Therapies Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Plasma-derived Therapies Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Plasma-derived Therapies Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Plasma-derived Therapies Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Plasma-derived Therapies Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Plasma-derived Therapies Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Plasma-derived Therapies Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Plasma-derived Therapies Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Plasma-derived Therapies Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Plasma-derived Therapies
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Plasma-derived Therapies Market Size (M USD), 2019-2030
Figure 5. Global Plasma-derived Therapies Market Size (M USD) (2019-2030)
Figure 6. Global Plasma-derived Therapies Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Plasma-derived Therapies Market Size by Country (M USD)
Figure 11. Plasma-derived Therapies Sales Share by Manufacturers in 2023
Figure 12. Global Plasma-derived Therapies Revenue Share by Manufacturers in 2023
Figure 13. Plasma-derived Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Plasma-derived Therapies Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Plasma-derived Therapies Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Plasma-derived Therapies Market Share by Type
Figure 18. Sales Market Share of Plasma-derived Therapies by Type (2019-2024)
Figure 19. Sales Market Share of Plasma-derived Therapies by Type in 2023
Figure 20. Market Size Share of Plasma-derived Therapies by Type (2019-2024)
Figure 21. Market Size Market Share of Plasma-derived Therapies by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Plasma-derived Therapies Market Share by Application
Figure 24. Global Plasma-derived Therapies Sales Market Share by Application (2019-2024)
Figure 25. Global Plasma-derived Therapies Sales Market Share by Application in 2023
Figure 26. Global Plasma-derived Therapies Market Share by Application (2019-2024)
Figure 27. Global Plasma-derived Therapies Market Share by Application in 2023
Figure 28. Global Plasma-derived Therapies Sales Growth Rate by Application (2019-2024)
Figure 29. Global Plasma-derived Therapies Sales Market Share by Region (2019-2024)
Figure 30. North America Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Plasma-derived Therapies Sales Market Share by Country in 2023
Figure 32. U.S. Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Plasma-derived Therapies Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Plasma-derived Therapies Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Plasma-derived Therapies Sales Market Share by Country in 2023
Figure 37. Germany Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Plasma-derived Therapies Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Plasma-derived Therapies Sales Market Share by Region in 2023
Figure 44. China Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Plasma-derived Therapies Sales and Growth Rate (K Units)
Figure 50. South America Plasma-derived Therapies Sales Market Share by Country in 2023
Figure 51. Brazil Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Plasma-derived Therapies Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Plasma-derived Therapies Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Plasma-derived Therapies Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Plasma-derived Therapies Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Plasma-derived Therapies Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Plasma-derived Therapies Market Share Forecast by Type (2025-2030)
Figure 65. Global Plasma-derived Therapies Sales Forecast by Application (2025-2030)
Figure 66. Global Plasma-derived Therapies Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Plasma-derived Therapies
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Plasma-derived Therapies Market Size (M USD), 2019-2030
Figure 5. Global Plasma-derived Therapies Market Size (M USD) (2019-2030)
Figure 6. Global Plasma-derived Therapies Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Plasma-derived Therapies Market Size by Country (M USD)
Figure 11. Plasma-derived Therapies Sales Share by Manufacturers in 2023
Figure 12. Global Plasma-derived Therapies Revenue Share by Manufacturers in 2023
Figure 13. Plasma-derived Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Plasma-derived Therapies Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Plasma-derived Therapies Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Plasma-derived Therapies Market Share by Type
Figure 18. Sales Market Share of Plasma-derived Therapies by Type (2019-2024)
Figure 19. Sales Market Share of Plasma-derived Therapies by Type in 2023
Figure 20. Market Size Share of Plasma-derived Therapies by Type (2019-2024)
Figure 21. Market Size Market Share of Plasma-derived Therapies by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Plasma-derived Therapies Market Share by Application
Figure 24. Global Plasma-derived Therapies Sales Market Share by Application (2019-2024)
Figure 25. Global Plasma-derived Therapies Sales Market Share by Application in 2023
Figure 26. Global Plasma-derived Therapies Market Share by Application (2019-2024)
Figure 27. Global Plasma-derived Therapies Market Share by Application in 2023
Figure 28. Global Plasma-derived Therapies Sales Growth Rate by Application (2019-2024)
Figure 29. Global Plasma-derived Therapies Sales Market Share by Region (2019-2024)
Figure 30. North America Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Plasma-derived Therapies Sales Market Share by Country in 2023
Figure 32. U.S. Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Plasma-derived Therapies Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Plasma-derived Therapies Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Plasma-derived Therapies Sales Market Share by Country in 2023
Figure 37. Germany Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Plasma-derived Therapies Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Plasma-derived Therapies Sales Market Share by Region in 2023
Figure 44. China Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Plasma-derived Therapies Sales and Growth Rate (K Units)
Figure 50. South America Plasma-derived Therapies Sales Market Share by Country in 2023
Figure 51. Brazil Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Plasma-derived Therapies Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Plasma-derived Therapies Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Plasma-derived Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Plasma-derived Therapies Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Plasma-derived Therapies Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Plasma-derived Therapies Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Plasma-derived Therapies Market Share Forecast by Type (2025-2030)
Figure 65. Global Plasma-derived Therapies Sales Forecast by Application (2025-2030)
Figure 66. Global Plasma-derived Therapies Market Share Forecast by Application (2025-2030)
